BELITE BIO, INC

BLTE

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001889109

SEC filings (opens in a new tab)

Insider trades, last 90 days

0 buys · 4 sells

Sold $32.02M
Open-market purchases (P) and sales (S), counted by Form 4 filing.

View insider trades

13F holders, Q2 2026

80

+5 vs. Q1 2026
Total value $1.44B

View 13F holders

Superinvestors holding BLTE

2

At the end of Q2 2026

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by BLTE insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Sep 9, 20267:39 PM ET	Sep 4 – Sep 8, 2026	Lin Yu-HsinChief Executive Officer	SSaleAmerican depositary share	−100.44K	$189.999	−$19.08M	70.13K	−58.9%	SEC10b5-1
Sep 9, 20267:38 PM ET	Sep 4 – Sep 8, 2026	Chuang Hao-YuanChief Financial Officer	SSaleAmerican depositary share	−67.4K	$189.9774	−$12.8M	26.04K	−72.1%	SEC10b5-1
Aug 14, 20266:10 AM ET	Aug 12, 2026	Chuang Hao-YuanChief Financial Officer	SSaleAmerican depositary share	−367	$180.3463	−$66.19K	93.43K	−0.4%	SEC10b5-1
Aug 14, 20266:10 AM ET	Aug 12, 2026	Lin Yu-HsinChief Executive Officer	SSaleAmerican depositary share	−365	$180.3482	−$65.83K	170.57K	−0.2%	SEC10b5-1
Jun 22, 2026	Jun 18, 2026	Scholl Hendrik PeterChief Medical Officer	SSaleAmerican depositary share	−10K	$145.24	−$1.45M	15K	−40.0%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in BLTE at the end of Q2 2026.

Institutions holding BLTE in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Darwin Global Management, Ltd.	3,077,219	$456.59M	12.14%	+19,807+0.6%	Added
Paradigm Biocapital Advisors LP	1,232,877	$189.84M	3.55%	+118,093+10.6%	Added
RTW INVESTMENTS, LP	715,332	$110.15M	0.94%	00.0%	Unchanged
MILLENNIUM MANAGEMENT LLC	494,564	$76.16M	0.05%	−75,524−13.2%	Reduced
MAVERICK CAPITAL LTDSuperinvestorMaverick Capital	396,311	$61.03M	0.55%	+396,311	New